Clinical Trial Update: A Study of CDX-622 in Participants With Mild to Moderate Asthma [Phase 1]

View source ↗

Summary

Clinical trial update describes a Phase 1 study of CDX-622 in participants with mild to moderate asthma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CDX-622

Snippet

Sponsor: Celldex Therapeutics | Conditions: Mild to Moderate Asthma | Phase 1 | Status: RECRUITING